Product: Fulvestrant-d3
Catalog Number: D3621
Unlabeled CAS Number: 129453-61-8
Synonyms: (7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl], (7α, 17β)-estra-1,3,5(10)-triene-3,17-diol-d3;
Faslodex-D3
Pricing:
1 mg =  $890   Add to Cart
Formula: C32H44F5O3SD3
Enrichment: 98%D
Molecular Weight: 609.79
Structure: Fulvestrant-d<sub>3</sub>
Click image to enlarge
Category: Labeled Steroids & Hormones
Literature References:

Scott SM, Brown M, Come SE, Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer. Expert Opin Drug Saf, 2011, 10 (5): 819–26.; Croxtall JD, McKeage K., Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women. Drugs, 2011, 71 (3): 363–80.

MSDS: Click here.
Applications: A labeled estrogen receptor antagonist with no agonist effects. Used as a treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. A selective estrogen receptor down-regulator.